ArticleLeukemia2021

High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib.

Tiziano Barbui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.